Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder
10.1080/17425255.2018.1459564
Saved in:
Main Authors: | Renee-Marie Ragguett, Carola Rong, Joshua Rosenblat, Roger Ho, Roger S McIntyre |
---|---|
Other Authors: | DEPT OF PSYCHOLOGICAL MEDICINE |
Format: | Article |
Published: |
Taylor & Francis
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142027 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
by: Nelson Rodrigues, et al.
Published: (2020) -
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis
by: Danielle Cha, et al.
Published: (2024) -
Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches
by: Li, Zhifei, et al.
Published: (2022) -
Drug-Drug Interactions as a Result of Co-Administering ?9-THC and CBD with Other Psychotropic Agents
by: Carola Rong, et al.
Published: (2018) -
Efficacy of dextromethorphan for the treatment of depression: A systematic review of preclinical and clinical trials
by: Amna Majeed, et al.
Published: (2021)